Prognostic Value of Sarcopenia in Lung Cancer

医学 肌萎缩 肺癌 内科学 危险系数 肿瘤科 前瞻性队列研究 回顾性队列研究 癌症 比例危险模型 队列研究 子群分析 荟萃分析 置信区间
作者
Ming Yang,Yanjiao Shen,Lingling Tan,Weimin Li
出处
期刊:Chest [Elsevier BV]
卷期号:156 (1): 101-111 被引量:239
标识
DOI:10.1016/j.chest.2019.04.115
摘要

Background Evidence regarding the association between sarcopenia (skeletal muscle depletion) and outcomes in patients with lung cancer varies across studies. We aimed to systematically review the prognostic value of sarcopenia in lung cancer. Methods We searched Ovid MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials through July 23, 2018 to identify retrospective or prospective cohort studies. We applied the Quality in Prognostic Studies instrument to assess the risk of bias in individual studies. We examined the heterogeneity and publication bias and performed subgroup analyses and sensitivity analyses. Results We included 13 studies (1,810 participants). The pooled prevalence of sarcopenia was 43% in patients with non-small cell lung cancer (NSCLC) and 52% in patients with small cell lung cancer (SCLC). Sarcopenia was associated with a shorter overall survival (OS) in patients with lung cancer (hazard ratio [HR], 2.23; 95% CI, 1.68-2.94). This association existed for both NSCLC (HR, 2.57; 95% CI, 1.79-3.68) and SCLC (HR, 1.59; 95% CI, 1.17-2.14). Sarcopenia was an independent predictor of shorter OS in both stage I-II NSCLC (HR, 3.23; 95% CI, 1.68-6.23) and stage III-IV NSCLC (HR, 2.19; 95% CI, 1.14-4.24). However, sarcopenia was not an independent predictor of disease-free survival in patients with NSCLC (HR, 1.28; 95% CI, 0.44-3.69). Conclusions Sarcopenia is highly prevalent in patients with lung cancer (approximately one in two) and an important predictor of impaired OS in patients with SCLC or with different stages of NSCLC. Evidence regarding the association between sarcopenia (skeletal muscle depletion) and outcomes in patients with lung cancer varies across studies. We aimed to systematically review the prognostic value of sarcopenia in lung cancer. We searched Ovid MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials through July 23, 2018 to identify retrospective or prospective cohort studies. We applied the Quality in Prognostic Studies instrument to assess the risk of bias in individual studies. We examined the heterogeneity and publication bias and performed subgroup analyses and sensitivity analyses. We included 13 studies (1,810 participants). The pooled prevalence of sarcopenia was 43% in patients with non-small cell lung cancer (NSCLC) and 52% in patients with small cell lung cancer (SCLC). Sarcopenia was associated with a shorter overall survival (OS) in patients with lung cancer (hazard ratio [HR], 2.23; 95% CI, 1.68-2.94). This association existed for both NSCLC (HR, 2.57; 95% CI, 1.79-3.68) and SCLC (HR, 1.59; 95% CI, 1.17-2.14). Sarcopenia was an independent predictor of shorter OS in both stage I-II NSCLC (HR, 3.23; 95% CI, 1.68-6.23) and stage III-IV NSCLC (HR, 2.19; 95% CI, 1.14-4.24). However, sarcopenia was not an independent predictor of disease-free survival in patients with NSCLC (HR, 1.28; 95% CI, 0.44-3.69). Sarcopenia is highly prevalent in patients with lung cancer (approximately one in two) and an important predictor of impaired OS in patients with SCLC or with different stages of NSCLC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S的应助被郑瑞欣采纳,获得10
1秒前
声声发布了新的文献求助10
2秒前
3秒前
3秒前
4秒前
怡然蘑菇完成签到,获得积分10
4秒前
Dyying发布了新的文献求助10
4秒前
4秒前
慕青的应助被新嘟采纳,获得10
5秒前
ds发布了新的文献求助10
6秒前
8秒前
霸气乐荷完成签到 ,获得积分10
9秒前
哈哈哈完成签到 ,获得积分10
9秒前
学做科研发布了新的文献求助10
9秒前
纸杯蛋糕完成签到 ,获得积分10
10秒前
10秒前
温庭筠发布了新的文献求助10
11秒前
11秒前
油面摊子完成签到,获得积分10
11秒前
Cbdd_发布了新的文献求助10
15秒前
郑瑞欣发布了新的文献求助10
15秒前
秋瑾完成签到,获得积分10
16秒前
李爱国的应助被斯文雅旋采纳,获得10
16秒前
午夜小南瓜完成签到 ,获得积分10
16秒前
温庭筠完成签到,获得积分10
16秒前
一丢丢完成签到,获得积分10
17秒前
科研通AI65的应助被科研通管家采纳,获得20
17秒前
星辰大海的应助被科研通管家采纳,获得10
17秒前
丘比特的应助被科研通管家采纳,获得30
17秒前
毅然决然必然完成签到,获得积分10
17秒前
17秒前
18秒前
脑洞疼的应助被科研通管家采纳,获得10
18秒前
核桃的应助被科研通管家采纳,获得30
18秒前
共享精神的应助被科研通管家采纳,获得10
18秒前
大模型的应助被科研通管家采纳,获得10
18秒前
fantasy的应助被科研通管家采纳,获得10
18秒前
18秒前
小北完成签到,获得积分10
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186875
求助须知:如何正确求助?哪些是违规求助? 9575211
关于积分的说明 21840004
捐赠科研通 7784592
什么是DOI,文献DOI怎么找? 3434866
关于科研通互助平台的介绍 2559266
邀请新用户注册赠送积分活动 2481717